Business ❯Healthcare ❯Pharmaceuticals

Oncology

Cisplatin-Induced Ototoxicity Sales Performance Gastrointestinal Cancers

GSK Acquires US Biotech IDRx in $1.15 Billion Deal to Advance Rare Cancer Treatment

Johnson & Johnson Raises Revenue Forecast Despite Legal Costs Impact